In a randomized controlled trial, the investigators wish to investigate, if oncologic treatment decision based on G8 screening followed by geriatric assessment and subsequent MDT, if needed, in older frail patients with gynaecologic and urologic cancer is superior to standard assessment (PS and clinical assessment) in oncologic treatment decision.

Inclusion Criteria:

• Histologically verified gynaecologic cancer (ovarian, uterine, or cervical cancer) or urologic cancer (prostate, bladder, or kidney cancer).
• Suited for first line medical oncologic treatment with chemotherapy and/or targeted therapy.
• Age ≥ 70 years.
• Understands, speaks, and writes Danish.
• Signed informed consent.

Exclusion Criteria:

• Previous cancer diagnosis except for carcinoma in situ of the cervix or skin cancer other than malignant melanoma.
• Previous chemotherapy and/or targeted therapy for current cancer diagnosis.
• Previous radiation therapy or concomitant radiotherapy for current cancer diagnosis.
• Surgery within the last 4 weeks.